These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 2545087)
1. An in-vitro study on ciprofloxacin and other anti-microbials against gram-negative bacteria isolated from patients in Ibadan, Nigeria. Rotowa NA; Montefiore D; Adeyemi-Doro FA Afr J Med Med Sci; 1989 Mar; 18(1):63-7. PubMed ID: 2545087 [TBL] [Abstract][Full Text] [Related]
2. Comparative in-vitro activities of commonly available quinolones and other antibiotics on bacterial isolates in Ibadan, Nigeria. Oni AA; Bakare RA; Arowojolu AO; Kehinde Toki RA; Fasina NA Afr J Med Med Sci; 2001; 30(1-2):35-7. PubMed ID: 14510147 [TBL] [Abstract][Full Text] [Related]
3. Identification and pretherapy susceptibility of pathogens in patients with complicated urinary tract infection or acute pyelonephritis enrolled in a clinical study in the United States from November 2004 through April 2006. Peterson J; Kaul S; Khashab M; Fisher A; Kahn JB Clin Ther; 2007 Oct; 29(10):2215-21. PubMed ID: 18042477 [TBL] [Abstract][Full Text] [Related]
4. Antimicrobial activity of fluoroquinolones and other antibiotics on 1,116 clinical gram-positive and gram-negative isolates. Mascellino MT; Farinelli S; Iegri F; Iona E; De Simone C Drugs Exp Clin Res; 1998; 24(3):139-51. PubMed ID: 9825230 [TBL] [Abstract][Full Text] [Related]
5. In vitro activity of ertapenem: review of recent studies. Wexler HM J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii11-21. PubMed ID: 15150179 [TBL] [Abstract][Full Text] [Related]
6. Bacterial isolates in the sick young infant in Ile-Ife, Nigeria. Adejuyigbe EA; Ako-Nai AK; Adisa B J Trop Pediatr; 2004 Dec; 50(6):323-7. PubMed ID: 15537715 [TBL] [Abstract][Full Text] [Related]
7. Characterization and anti-microbial susceptibility of gram-negative bacteria isolated from bloodstream infections of cancer patients on chemotherapy in Pakistan. Saghir S; Faiz M; Saleem M; Younus A; Aziz H Indian J Med Microbiol; 2009; 27(4):341-7. PubMed ID: 19736404 [TBL] [Abstract][Full Text] [Related]
8. Comparison of in vitro activities of levofloxacin, ciprofloxacin, ceftazidime, cefepime, imipenem, and piperacillin-tazobactam against aerobic bacterial pathogens from patients with nosocomial infections. Huang SS; Lee SC; Lee N; See LC; Tsai MH; Shieh WB J Microbiol Immunol Infect; 2007 Apr; 40(2):134-40. PubMed ID: 17446961 [TBL] [Abstract][Full Text] [Related]
9. Comparative in vitro activity of ciprofloxacin against aerobic and anaerobic bacteria from clinical isolates. Klietmann W; Focht J; Nösner K Arzneimittelforschung; 1987 Jun; 37(6):661-6. PubMed ID: 2822054 [TBL] [Abstract][Full Text] [Related]
10. Antibiotic susceptibility of bacteria isolated from cats with ulcerative keratitis in Taiwan. Lin CT; Petersen-Jones SM J Small Anim Pract; 2008 Feb; 49(2):80-3. PubMed ID: 17850276 [TBL] [Abstract][Full Text] [Related]
11. Bacterial incidence and antibiotic sensitivity pattern in moderate and severe infections in hospitalised patients. Ghosh A; Karmakar PS; Pal J; Chakraborty N; Debnath NB; Mukherjee JD J Indian Med Assoc; 2009 Jan; 107(1):21-2, 24-5. PubMed ID: 19588683 [TBL] [Abstract][Full Text] [Related]
12. [In vitro activity of several antibiotics on pathogenic micro-organisms isolated from the lower respiratory tract]. Allocco A; Tullio V; Cuffini AM; Carlone NA G Batteriol Virol Immunol; 1994; 86(1-12):15-28. PubMed ID: 8706972 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of the in vitro activity of 9 antimicrobials against bacterial strains isolated from patients in intensive care units in brazil: MYSTIC Antimicrobial Surveillance Program. Mendes C; Hsiung A; Kiffer C; Oplustil C; Sinto S; Mimica I; Zoccoli C; Braz J Infect Dis; 2000 Oct; 4(5):236-44. PubMed ID: 11063555 [TBL] [Abstract][Full Text] [Related]
14. Changing bacterial isolates and antibiotic sensitivities of purulent dacryocystitis. Briscoe D; Rubowitz A; Assia E Orbit; 2005 Mar; 24(1):29-32. PubMed ID: 15764113 [TBL] [Abstract][Full Text] [Related]
15. Multidrug-resistant Gram-negative bacteria in postoperative infections. Singh AV; Mishra B; Thakur A J Indian Med Assoc; 2009 Mar; 107(3):148-50, 163. PubMed ID: 19810380 [TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo activities of DW-224a, a novel fluoroquinolone antibiotic agent. Kwon AR; Min YH; Ryu JM; Choi DR; Shim MJ; Choi EC J Antimicrob Chemother; 2006 Sep; 58(3):684-8. PubMed ID: 16873394 [TBL] [Abstract][Full Text] [Related]
17. In vitro activity of moxifloxacin against common clinical bacterial isolates in Taiwan. Sheng WH; Wang JT; Chen YC; Chang SC; Luh KT J Microbiol Immunol Infect; 2001 Sep; 34(3):178-84. PubMed ID: 11605808 [TBL] [Abstract][Full Text] [Related]
18. Incidence of multiple antibiotic resistant Gram-negative bacteria isolated from surface and underground water sources in south western region of Nigeria. Oluyege JO; Dada AC; Odeyemi AT Water Sci Technol; 2009; 59(10):1929-36. PubMed ID: 19474486 [TBL] [Abstract][Full Text] [Related]
19. In vitro activity of tigecycline against resistant micro-organisms isolated from burn patients. Timurkaynak F; Arslan H; Azap OK; Senger SS; Başaran O; Karaman SO; Haberal M Burns; 2008 Nov; 34(7):1033-6. PubMed ID: 18539397 [TBL] [Abstract][Full Text] [Related]
20. [Urinary infection. I. Comparative in vitro activities of several antibiotic drugs against Gram-negative bacteria]. Giachino F; Allocco A; Tuninetti L; Tullio V; Cuffini AM; Carlone NA G Batteriol Virol Immunol; 1992 Jan-1993 Dec; 85(1-12):55-67. PubMed ID: 7498617 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]